Pertussis vaccination responses in COPD patients

FHS
July 21, 2023
10:27 am

Researchers evaluated the humoral and cellular immune responses to pertussis vaccination in COPD patients.

4DMT provides clinical programme updates for its wet AMD gene therapy – Pharmaceutical Technology

Detailed Phase II results are expected in the first half of 2024. Image Credit: Net Vector / Shutterstock. 4D Molecular Therapeutics (4DMT) has provided a

July 18, 2023

Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results – Biotech Investments

EQS-News: Nyxoah SA. / Key word(s): Quarter Results Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results 06.08.2024 / 22:05 CET/CEST The

August 7, 2024

FDA Approves New Agent for Nerve Pain From Rare Inherited Disease

Eplontersen (Wainua) was approved by the FDA to treat polyneuropathy associated with hereditary transthyretin-mediated amyloidosis (ATTR) in adults, Ionis Pharmaceuticals and AstraZeneca announced on Thursday.

December 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.